Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration

Neuroscience. 1997 Jan;76(1):167-76. doi: 10.1016/s0306-4522(96)00363-6.

Abstract

Protracted changes in basal "steady-state" opioid peptide gene expression in the brain may represent adaptations underlying the behavioral effects of drugs of abuse, observed long after drug exposure. Here, we have studied the long-term effects of two distinct regimens of morphine administration ("intermittent" vs "chronic" morphine treatment) on behavioral sensitization and "steady-state" striatal preprodynorphin and preproenkephalin gene expression in rats. Opioid peptide gene expression was investigated using in situ hybridization at three rostrocaudal levels (rostral, intermediate and caudal) of the caudate-putamen and the nucleus accumbens. Behavioral studies showed that the intermittent morphine treatment resulted in a significantly greater enhancement of morphine-induced locomotion than the chronic morphine treatment three weeks after cessation of opiate exposure. The intermittent morphine treatment resulted in an initial decrease of preprodynorphin gene expression of about 5-10% in the caudate-putamen and the nucleus accumbens at the rostral and intermediate levels one day after the last morphine administration. In contrast, a protracted increase of preprodynorphin gene expression of about 20% throughout the caudate-putamen and of about 6% in intermediate sections of the nucleus accumbens was observed 21 days after cessation of intermittent morphine treatment. Although the chronic morphine treatment induced a decrease of preprodynorphin messenger RNA levels one day after the last administration, no significant changes were observed three weeks after cessation of chronic morphine treatment. No long-term changes were observed in preproenkephalin gene expression after either morphine treatment. Since the intermittent morphine administration induced long-term behavioral sensitization much more effectively than the chronic morphine treatment, we tentatively suggest that the protracted increase of preprodynorphin gene expression may play a facilitative role in the long-term character of opiate-induced behavioral sensitization.

MeSH terms

  • Animals
  • Autoradiography
  • Behavior, Animal / drug effects*
  • Corpus Striatum / physiology*
  • Dynorphins / genetics*
  • Enkephalins / genetics
  • Gene Expression / drug effects*
  • Male
  • Morphine / administration & dosage*
  • Morphine / pharmacology
  • Motor Activity / drug effects
  • Narcotics / administration & dosage*
  • Narcotics / pharmacology
  • Protein Precursors / genetics*
  • Rats
  • Rats, Wistar
  • Time Factors
  • Tissue Distribution

Substances

  • Enkephalins
  • Narcotics
  • Protein Precursors
  • pre-prodynorphin
  • Dynorphins
  • Morphine
  • preproenkephalin